Skip to content
Episode 64: Tipping Point Analysis in Clinical Trials episode artwork

Sep 18, 2026 10 min

Episode 64: Tipping Point Analysis in Clinical Trials

from QCast: Data-Driven Dialogue in Drug Development Hosted by Quanticate

Tipping point analysis helps trial teams understand how strongly a study conclusion depends on assumptions about missing data. In this QCast episode, co-hosts Jullia and Tom discuss how the method relates to MAR and MNAR, how delta adjustments can identify a tipping point, and why the numerical result still needs clinical interpretation. Key Takeaways Tipping point analysis tests how far assumptions about missing outcomes must change before a predefined trial conclusion changes. The tipping point needs to be interpreted in clinical context, including the endpoint scale, reasons for missingness, and number of participants affected. Continuous, binary, and time-to-event endpoints require different approaches, and prespecification helps keep the analysis aligned with the intended clinical question. 🔗 Learn More & Get Support: Visit quanticate.com to explore our biometrics services and discover how we can support your next clinical trial. 📝 Episode Notes & Transcript: Find show notes, resources, and a full transcript at quanticate.com/podcast. 🔔 Stay Connected: Subscribe to QCast on Apple Podcasts, Spotify, or your favourite platform to never miss an episode. About Quanticate Founded in 1994, Quanticate is a biometrics-focused CRO with over 30 years' experience delivering expert clinical and post-marketing data services worldwide. Specialising in the collection, management, standardisation, analysis, and reporting of data, we support pharma and biotech companies globally with high-quality solutions for clinical development. We specialise in: Clinical Data Capture & Management Biostatistics & Statistical Consultancy Statistical Programming & PK/PD Analysis Medical Writing & Pharmacovigilance Regulatory & Submission Support AI & Automation Post-Marketing Safety & Real-World Data Quanticate is committed to delivering expertise and solutions that drive the success of clinical development worldwide.

Episode details come from the podcast's RSS feed.

Embed this episode

Tipping point analysis helps trial teams understand how strongly a study conclusion depends on assumptions about missing data. In this QCast episode, co-hosts Jullia and Tom discuss how the method relates to MAR and MNAR, how delta adjustments can identify a tipping point, and why the numerical result still needs clinical interpretation. Key Takeaways Tipping point analysis tests how far assumptions about missing outcomes must change before a predefined trial conclusion changes.The tipping po...

Ready to play

Episode 64: Tipping Point Analysis in Clinical Trials

0:00 10:13

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of QCast: Data-Driven Dialogue in Drug Development?

This episode is 10 minutes long.

When was this QCast: Data-Driven Dialogue in Drug Development episode published?

This episode was published on September 18, 2026.

Can I download this QCast: Data-Driven Dialogue in Drug Development episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.